Cargando…
Natural Born Killers: NK Cells in Cancer Therapy
Cellular therapy has emerged as an attractive option for the treatment of cancer, and adoptive transfer of chimeric antigen receptor (CAR) expressing T cells has gained FDA approval in hematologic malignancy. However, limited efficacy was observed using CAR-T therapy in solid tumors. Natural killer...
Autores principales: | Franks, S. Elizabeth, Wolfson, Benjamin, Hodge, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465121/ https://www.ncbi.nlm.nih.gov/pubmed/32751977 http://dx.doi.org/10.3390/cancers12082131 |
Ejemplares similares
-
Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy
por: Wolfson, Benjamin, et al.
Publicado: (2021) -
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
por: Carrega, Paolo, et al.
Publicado: (2017) -
Natural born killers.
por: Schmidt, C W
Publicado: (1998) -
Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
por: Islam, Rasa, et al.
Publicado: (2021) -
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)